Brain-Derived Neurotrophic Factor Secreting Human Mesenchymal Stem Cells Improve Outcomes in Rett Syndrome Mouse Models
Open Access
- 6 October 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neuroscience
Abstract
Rett syndrome (RTT) is a severe X-linked dominant neurodevelopmental disorder caused by mutations in the methyl-CpG-binding protein 2 (MECP2) gene; MeCP2 regulates the expression of brain-derived neurotrophic factor (BDNF) and increasing BDNF levels ameliorates RTT symptoms. However, the clinical application of BDNF is limited, because of its short half-life and low penetrance across the blood-brain barrier. In this study, we generated BDNF-secreting mesenchymal stem cells (MSCs) from the human umbilical cord cells, using CRISPR-Cas9. We studied the effects of BDNF-MSCs in MECP2 knockout and MECP2-deficient mice. BDNF-MSCs upregulated the expression of BDNF, pAKT, and pERK1/2 and downregulated that of pp38, both in vitro and in vivo. In our in vivo experiments, BDNF-MSCs increased the body and brain weights in mice. BDNF-MSCs increased the neuronal cell numbers in the hippocampus, cortex, and striatum; in addition, they increased the number of synapses. BDNF-MSCs upregulated BDNF and the activity of BDNF downstream effectors, such as pAKT and pERK 1/2; this upregulation was persistent. In conclusion, BDNF-MSCs generated using CRISPR-Cas9 could be a therapeutic strategy for treating RTT.Keywords
This publication has 30 references indexed in Scilit:
- Brain-derived neurotrophic factor delivered to the brain using poly (lactide-co-glycolide) nanoparticles improves neurological and cognitive outcome in mice with traumatic brain injuryDrug Delivery, 2016
- PTP1B inhibition suggests a therapeutic strategy for Rett syndromeJCI Insight, 2015
- Protein-tyrosine Phosphatase 1B (PTP1B) Is a Novel Regulator of Central Brain-derived Neurotrophic Factor and Tropomyosin Receptor Kinase B (TrkB) SignalingOnline Journal of Public Health Informatics, 2014
- MeCP2 phosphorylation in the brain: from transcription to behaviorBiological Chemistry, 2013
- Glucocorticoid suppresses BDNF-stimulated MAPK/ERK pathway via inhibiting interaction of Shp2 with TrkBFEBS Letters, 2011
- Rett syndrome diagnostic criteria: Lessons from the Natural History StudyAnnals of Neurology, 2010
- Local injection of BDNF producing mesenchymal stem cells increases neuronal survival and synaptic stability following ventral root avulsionNeurobiology of Disease, 2009
- MeCP2 Deficiency in the Brain Decreases BDNF Levels by REST/CoREST-Mediated Repression and Increases TRKB ProductionEpigenetics, 2007
- MECP2 mutations in malesJournal of Medical Genetics, 2007
- Neurotrophic factors in the pathogenesis of Rett syndrome.Journal of Child Neurology, 2003